IL144892A0 - Therapeutic agent for intermittent claudication - Google Patents
Therapeutic agent for intermittent claudicationInfo
- Publication number
- IL144892A0 IL144892A0 IL14489200A IL14489200A IL144892A0 IL 144892 A0 IL144892 A0 IL 144892A0 IL 14489200 A IL14489200 A IL 14489200A IL 14489200 A IL14489200 A IL 14489200A IL 144892 A0 IL144892 A0 IL 144892A0
- Authority
- IL
- Israel
- Prior art keywords
- therapeutic agent
- intermittent claudication
- claudication
- intermittent
- therapeutic
- Prior art date
Links
- 206010022562 Intermittent claudication Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 208000021156 intermittent vascular claudication Diseases 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11050150A JP2000247882A (ja) | 1999-02-26 | 1999-02-26 | 間歇性跛行治療薬 |
PCT/JP2000/001046 WO2000051604A1 (fr) | 1999-02-26 | 2000-02-24 | Remedes contre la claudication intermittente |
Publications (1)
Publication Number | Publication Date |
---|---|
IL144892A0 true IL144892A0 (en) | 2002-06-30 |
Family
ID=12851167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14489200A IL144892A0 (en) | 1999-02-26 | 2000-02-24 | Therapeutic agent for intermittent claudication |
Country Status (19)
Country | Link |
---|---|
US (1) | US6476049B2 (pt) |
EP (1) | EP1155693A4 (pt) |
JP (1) | JP2000247882A (pt) |
KR (1) | KR20010102388A (pt) |
CN (1) | CN1407892A (pt) |
AU (1) | AU2690700A (pt) |
BG (1) | BG105826A (pt) |
BR (1) | BR0008543A (pt) |
CA (1) | CA2373463A1 (pt) |
CZ (1) | CZ20013048A3 (pt) |
HU (1) | HUP0200113A3 (pt) |
IL (1) | IL144892A0 (pt) |
MX (1) | MXPA01008669A (pt) |
NO (1) | NO20014125L (pt) |
NZ (1) | NZ513687A (pt) |
SK (1) | SK12132001A3 (pt) |
WO (1) | WO2000051604A1 (pt) |
YU (1) | YU62101A (pt) |
ZA (1) | ZA200106782B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000247882A (ja) | 1999-02-26 | 2000-09-12 | Ajinomoto Co Inc | 間歇性跛行治療薬 |
EP1430890A4 (en) * | 2001-09-26 | 2007-01-17 | Mitsubishi Pharma Corp | THROMBUS / THROMBOGENESIS INHIBITORS |
CN114796182B (zh) * | 2021-01-27 | 2023-12-12 | 中国海洋大学 | 益母草碱在用于制备防治间歇性跛行的药物中的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100351012B1 (ko) * | 1994-04-20 | 2002-12-26 | 아지노모토 가부시키가이샤 | 피페리딘유도체및이를함유하는항혈소판제 |
JP2962186B2 (ja) * | 1994-04-20 | 1999-10-12 | 味の素株式会社 | ピペリジン誘導体及びそれを含有するセロトニン拮抗薬 |
AU6230398A (en) * | 1997-02-27 | 1998-09-18 | Ajinomoto Co., Inc. | Thrombolytic agent |
JP2000247882A (ja) | 1999-02-26 | 2000-09-12 | Ajinomoto Co Inc | 間歇性跛行治療薬 |
-
1999
- 1999-02-26 JP JP11050150A patent/JP2000247882A/ja active Pending
-
2000
- 2000-02-24 CZ CZ20013048A patent/CZ20013048A3/cs unknown
- 2000-02-24 WO PCT/JP2000/001046 patent/WO2000051604A1/ja not_active Application Discontinuation
- 2000-02-24 IL IL14489200A patent/IL144892A0/xx unknown
- 2000-02-24 NZ NZ513687A patent/NZ513687A/xx not_active Application Discontinuation
- 2000-02-24 MX MXPA01008669A patent/MXPA01008669A/es unknown
- 2000-02-24 CA CA002373463A patent/CA2373463A1/en not_active Abandoned
- 2000-02-24 CN CN00806843A patent/CN1407892A/zh active Pending
- 2000-02-24 EP EP00905302A patent/EP1155693A4/en not_active Withdrawn
- 2000-02-24 BR BR0008543-0A patent/BR0008543A/pt not_active IP Right Cessation
- 2000-02-24 KR KR1020017010833A patent/KR20010102388A/ko not_active Application Discontinuation
- 2000-02-24 HU HU0200113A patent/HUP0200113A3/hu unknown
- 2000-02-24 SK SK1213-2001A patent/SK12132001A3/sk unknown
- 2000-02-24 AU AU26907/00A patent/AU2690700A/en not_active Abandoned
- 2000-02-24 YU YU62101A patent/YU62101A/sh unknown
-
2001
- 2001-08-16 ZA ZA200106782A patent/ZA200106782B/en unknown
- 2001-08-16 BG BG105826A patent/BG105826A/xx unknown
- 2001-08-22 US US09/933,908 patent/US6476049B2/en not_active Expired - Fee Related
- 2001-08-24 NO NO20014125A patent/NO20014125L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0200113A2 (en) | 2002-06-29 |
EP1155693A4 (en) | 2006-12-27 |
SK12132001A3 (sk) | 2001-12-03 |
EP1155693A1 (en) | 2001-11-21 |
ZA200106782B (en) | 2002-08-16 |
HUP0200113A3 (en) | 2002-12-28 |
YU62101A (sh) | 2004-07-15 |
MXPA01008669A (es) | 2002-03-14 |
US20020037906A1 (en) | 2002-03-28 |
NO20014125D0 (no) | 2001-08-24 |
US6476049B2 (en) | 2002-11-05 |
AU2690700A (en) | 2000-09-21 |
BG105826A (en) | 2002-04-30 |
JP2000247882A (ja) | 2000-09-12 |
CA2373463A1 (en) | 2000-09-08 |
NZ513687A (en) | 2001-09-28 |
NO20014125L (no) | 2001-08-24 |
WO2000051604A1 (fr) | 2000-09-08 |
CN1407892A (zh) | 2003-04-02 |
BR0008543A (pt) | 2001-11-06 |
CZ20013048A3 (cs) | 2002-01-16 |
KR20010102388A (ko) | 2001-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9911863D0 (en) | Therapeutic agents | |
GB9905010D0 (en) | Therapeutic agents | |
IL150030A0 (en) | Therapeutic agents | |
GB9904786D0 (en) | Therapeutic agents | |
GB9929685D0 (en) | Therapeutic agents | |
GB9929687D0 (en) | Therapeutic agents | |
GB9930570D0 (en) | Therapy | |
GB9921351D0 (en) | Therapeutic agents | |
GB9911881D0 (en) | Therapeutic agents | |
GB9907243D0 (en) | Therapy | |
PL339848A1 (en) | Therapeutic agent against hypephosphataemia | |
HK1047241A1 (zh) | 放射線防護劑 | |
GB9903476D0 (en) | Therapeutic agents | |
GB9929569D0 (en) | Therapeutic agents | |
GB9914744D0 (en) | Therapeutic agents | |
GB9900222D0 (en) | Therapeutic compounds | |
GB9903119D0 (en) | Therapeutic agents | |
GB0030067D0 (en) | Therapeutic agent | |
IL144892A0 (en) | Therapeutic agent for intermittent claudication | |
IL147078A0 (en) | Therapeutic agents | |
GB9914745D0 (en) | Therapeutic agents | |
GB9902881D0 (en) | Therapeutic agents | |
HK1041659A1 (zh) | 癌治療藥劑供給裝置 | |
HUP0105469A3 (en) | Therapeutic drugs comprising pyrroloazepines for treating intermittent claudication | |
GB9914743D0 (en) | Therapeutic agents |